The DOI matches its Crossref record; 60 of the 63 references it cites were found in a registry or an index.
Intestinal myofibroblasts in innate immune responses of the intestine
Open accessAbstract
Background & aims Intestinal myofibroblasts are known to respond to inflammatory signals and may play a role in Crohn's disease-associated fibrosis. However, putative involvement by myofibroblasts in innate immune responses as part of intestinal host defense has not been characterized. We therefore analyzed expression and regulation of toll-like receptors (TLRs) in colonic human myofibroblasts (CCD-18) and primary human colonic myofibroblasts in comparison with human lung myofibroblasts (CCD-37).Methods Expression of TLRs (1-10) and NOD 1 and 2 was assessed before and after stimulation with either lipopolysaccharide (LPS) or lipoteichoic acid (LTA) by using a custom microarray, reverse-transcription polymerase chain reaction, Northern blot and Western blot analysis, and immunohistochemistry. Activation of signaling pathways, translocation of p65, and secretion of interleukin (IL)-8 were determined.Results Messenger RNAs encoding for TLR1-9, as well as NOD1 and NOD2, were amplified from cultured and primary human intestinal myofibroblasts. After stimulation with LPS or LTA, a 1.5-4.2-fold up-regulation of TLRs (2, 3, 4, 6, 7) and elements of the signaling cascade (MyD88, TIR domain-containing adapter protein [TIRAP]) was observed. CCD-18 and CCD-37 cells expressed TLR 2 and 4 protein, which were located primarily on the cell membrane. Stimulation with LTA or LPS resulted in activation of the mitogen-activated protein kinases pathway, nuclear translocation of p65, and significantly increased IL-8 secretion.Conclusions Bacterial components directly activate intestinal myofibroblasts expressing TLRs. These cells may therefore participate in innate immune responses by sensing and responding to bacterial products that have penetrated into the subepithelial compartment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“‘Dysbiosis’, defined as an altered disease-associated microbiome, has been shown to increase with the severity of NASH in both rodents and in humans. This is paralleled and closely related to increased intestinal permeability, bacterial translocation into the portal system and activation of pro-inflammatory pathways.148”
From Understanding the cellular interactome of non-alcoholic fatty liver disease (2022) · cites this paper as [148]
In the citing paper
“The downstream kinase IRAK4 controlled pericyte myofibroblast conversion in vitro and pharmacological inhibition of MyD88 signaling with an IRAK4 inhibitor reduced fibrosis by attenuating tissue injury in vivo167”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [167]
In the citing paper
“In the kidney, pericytes, a myofibroblast precursor, activate a TLR2/TLR4/MyD88-dependent proinflammatory program in response to tissue injury167”
From Fibrosis: from mechanisms to medicines (2020) · cites this paper as [167]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Toll-like receptors and innate immunity
Medzhitov, R. (2001) · Nature Reviews Immunology · doi:10.1038/35100529 · Cited by 4,308
Alessi, D. R., Cuenda, A., Cohen, P., Dudley, D. T., & Saltiel, A. R. (1995) · Journal of Biological Chemistry · doi:10.1074/jbc.270.46.27489 · Cited by 3,396
Identification of a Novel Inhibitor of Mitogen-activated Protein Kinase Kinase
Favata, M. F., Horiuchi, K. Y., Manos, E. J., Daulerio, A. J., Stradley, D. A., Feeser, W. S., Dyk, D. E. V., Pitts, W. J., Earl, R. A., Hobbs, F. W., et al. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.29.18623 · Cited by 3,016
A MAP Kinase Targeted by Endotoxin and Hyperosmolarity in Mammalian Cells
Han, J., Lee, J. D., Bibbs, L., & Ulevitch, R. J. (1994) · Science · doi:10.1126/science.7914033 · Cited by 2,647
Cyclooxygenase in biology and disease
Dubois, R. N., Abramson, S. B., Crofford, L., Gupta, R., Simon, L. S., Putte, L., & Lipsky, P. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.12.1063 · Cited by 2,606
MD-2, a Molecule that Confers Lipopolysaccharide Responsiveness on Toll-like Receptor 4
Shimazu, R., Akashi, S., Ogata, H., Nagai, Y., Fukudome, K., Miyake, K., & Kimoto, M. (1999) · The Journal of Experimental Medicine · doi:10.1084/jem.189.11.1777 · Cited by 2,187
Ozinsky, A., Underhill, D. M., Fontenot, J. D., Hajjar, A. M., Smith, K. D., Wilson, C. B., Schroeder, L. A., & Aderem, A. A. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.250476497 · Cited by 2,086
Cuenda, A., Rouse, J., Doza, Y. N., Meier, R., Cohen, P., Gallagher, T. F., Young, P. R., & Lee, J. C. (1995) · FEBS Letters · doi:10.1016/0014-5793(95)00357-f · Cited by 2,086
Toll-like Receptor-4 Mediates Lipopolysaccharide-induced Signal Transduction
Chow, J. C., Young, D. W., Golenbock, D. T., Christ, W. J., & Gusovsky, F. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.16.10689 · Cited by 1,924
Peptidoglycan- and Lipoteichoic Acid-induced Cell Activation Is Mediated by Toll-like Receptor 2
Schwandner, R., Dziarski, R., Wesche, H., Rothe, M., & Kirschning, C. J. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.25.17406 · Cited by 1,704
Research works printed but not linked: 1
- Fiocchi, 1997, Intestinal inflammation, Am J Physiol, 273, G769
Cited by
Sorted by citations
Items 101–200 of 242
Inflammation, Innate Immunity, and the Intestinal Stromal Cell Niche: Opportunities and Challenges
Owens, B. M. J. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00319 · Cited by 54
Colonic epithelial response to injury requires Myd88 signaling in myeloid cells
Malvin, N. P., Seno, H., & Stappenbeck, T. S. (2012) · Mucosal Immunology · doi:10.1038/mi.2011.65 · Cited by 49
Contribution of Non-immune Cells to Activation and Modulation of the Intestinal Inflammation
Curciarello, R., Canziani, K. E., Docena, G. H., & Muglia, C. I. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00647 · Cited by 50
Nonimmune cells in inflammatory bowel disease: from victim to villain
Danese, S. (2008) · Trends in Immunology · doi:10.1016/j.it.2008.07.009 · Cited by 48
Stem cells as potential therapeutic targets for inflammatory bowel disease
Singh, S. R. (2010) · Frontiers in Bioscience-Scholar · doi:10.2741/s115 · Cited by 47
Lee, Y.-S., Yang, H., Yang, J.-Y., Kim, Y., Lee, S.-H., Kim, J. H., Jang, Y., Vallance, B., & Kweon, M. (2015) · Infection and Immunity · doi:10.1128/iai.00670-15 · Cited by 46
Brown, M., Hughes, K. R., Moossavi, S., Robins, A., & Mahida, Y. R. (2014) · Clinical & Experimental Immunology · doi:10.1111/cei.12381 · Cited by 47
CD90+ Stromal Cells are Non-Professional Innate Immune Effectors of the Human Colonic Mucosa
Owens, B. M. J., Steevels, T. A. M., Dudek, M., Walcott, D., Sun, M., Mayer, A., Allan, P., & Simmons, A. (2013) · Frontiers in Immunology · doi:10.3389/fimmu.2013.00307 · Cited by 47
The Molecular Mechanisms of Intestinal Inflammation and Fibrosis in Crohn’s Disease
Hayashi, Y., & Nakase, H. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.845078 · Cited by 46
Heidemann, J., Domschke, W., Kucharzik, T. F., & Maaser, C. (2006) · Infection and Immunity · doi:10.1128/iai.00248-06 · Cited by 46
de Bruyn, J. R., van den Brink, G. R., Steenkamer, J., Buskens, C. J., Bemelman, W. A., Meisner, S., Muncan, V., Velde, A. A. T., D’Haens, G., & Wildenberg, M. E. (2018) · Journal of Crohn s and Colitis · doi:10.1093/ecco-jcc/jjy036 · Cited by 47
Challenges in IBD Research 2024: Preclinical Human IBD Mechanisms
Ciorba, M. A., Konnikova, L., Hirota, S. A., Lucchetta, E. M., Turner, J. R., Slavin, A., Johnson, K., Condray, C. D., Hong, S., Cressall, B. K., et al. (2024) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izae081 · Cited by 44
Seiler, K. M., Bajinting, A., Alvarado, D. M., Traoré, M. A., Binkley, M. M., Goo, W. H., Lanik, W. E., Ou, J., Ismail, U., Iticovici, M. S., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-60672-5 · Cited by 43
Francoeur, C., Bouatrouss, Y., Seltana, A., Pinchuk, I. V., Vachon, P. H., Powell, D. W., Sawan, B., Seidman, E. G., & Beaulieu, J. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.10.014 · Cited by 42
Izzo, R., Bevivino, G., Simone, V. D., Sedda, S., Monteleone, I., Marafini, I., Giovangiulio, M. D., Rizzo, A., Franzè, E., Colantoni, A., et al. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy062 · Cited by 43
The Role of Airway Myofibroblasts in Asthma
Jendzjowsky, N. G., & Kelly, M. M. (2019) · CHEST Journal · doi:10.1016/j.chest.2019.08.1917 · Cited by 41
Therapeutic impact of toll-like receptors on inflammatory bowel diseases: A multiple-edged sword
Cario, E. (2007) · Inflammatory Bowel Diseases · doi:10.1002/ibd.20294 · Cited by 41
Importance of innate mucosal immunity and the promises it holds
Aich, P., & Dwivedy, A. (2011) · International Journal of General Medicine · doi:10.2147/ijgm.s17525 · Cited by 41
Zhang, Y., Liu, Z., Wang, K., Lu, S., Fan, S., Xu, L., & Cai, B. (2021) · International Journal of Biological Sciences · doi:10.7150/ijbs.57025 · Cited by 38
Biancheri, P., Sabatino, A. D., Rescigno, M., Giuffrida, P., Fornasa, G., Tsilingiri, K., Pender, S. L. F., Papadia, C., Wood, E., Pasini, A., et al. (2015) · Gut · doi:10.1136/gutjnl-2014-308876 · Cited by 38
Ulcerative colitis: immune function, tissue fibrosis and current therapeutic considerations
Maul, J., & Zeitz, M. (2011) · Langenbeck s Archives of Surgery · doi:10.1007/s00423-011-0789-4 · Cited by 38
Toll‐Like Receptor Signaling and its Relevance to Intestinal Inflammation
Cario, E., & Podolsky, D. K. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1326.006 · Cited by 38
Self-citationEnsarı, A., & Marsh, M. N. (2018) · Gastroenterology and hepatology from bed to bench. · Cited by 37
Reversibility of Stricturing Crohnʼs Disease—Fact or Fiction?
Bettenworth, D., & Rieder, F. (2015) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000598 · Cited by 35
Pinchuk, I. V., Beswick, E. J., Saada, J. I., Suárez, G., Winston, J. H., Mifflin, R. C., Mari, J. F. D., Powell, D. W., & Reyes, V. E. (2007) · The Journal of Immunology · doi:10.4049/jimmunol.178.12.8097 · Cited by 36
Probiotics manipulate host cytokine response and induce antimicrobial peptides
Trebichavský, I., & Šplı́chal, I. (2006) · Folia Microbiologica · doi:10.1007/bf02931599 · Cited by 36
Interleukin‐8 and CXCL10 expression in oral keratinocytes and fibroblasts via Toll‐like receptors
Fukui, A., Ohta, K., Nishi, H., Shigeishi, H., Tobiume, K., Takechi, M., & Kamata, N. (2012) · Microbiology and Immunology · doi:10.1111/1348-0421.12022 · Cited by 35
Margaritopoulos, G., Antoniou, K. M., Karagiannis, K., Samara, K. D., Lasithiotaki, I., Vassalou, E., Lymbouridou, R., Koutala, H., & Siafakas, N. M. (2010) · Fibrogenesis & Tissue Repair · doi:10.1186/1755-1536-3-20 · Cited by 35
Helicobacter pylori regulates TLR4 and TLR9 during gastric carcinogenesis.
Wang, T. R., Peng, J. C., Qiao, Y., Zhu, M., Zhao, D., Shen, J., & Ran, Z. H. (2014) · PubMed Central · Cited by 35
Innate Immunity and Apoptosis in IBD
Lichtenberger, G. S., Flavell, R. A., & Alexopoulou, L. (2004) · Inflammatory Bowel Diseases · doi:10.1097/00054725-200402001-00012 · Cited by 35
Immunologic regulation of toll-like receptors in gut epithelium
Abreu, M. T. (2003) · Current Opinion in Gastroenterology · doi:10.1097/00001574-200311000-00008 · Cited by 35
Gregorio, V. D., Imparato, G., Urciuolo, F., & Netti, P. A. (2018) · Acta Biomaterialia · doi:10.1016/j.actbio.2018.09.061 · Cited by 34
Zhang, Y., Lu, S., Fan, S., Xu, L., Jiang, X., Wang, K., & Cai, B. (2021) · Aging · doi:10.18632/aging.202505 · Cited by 33
Konstantinopoulos, P. A., Vandoros, G. P., Karamouzis, M. V., Gkermpesi, M., Sotiropoulou-Bonikou, G., & Papavassiliou, A. G. (2007) · Analytical Cellular Pathology · doi:10.1155/2007/831416 · Cited by 32
Filidou, E., Valatas, V., Drygiannakis, I., Arvanitidis, K. I., Vradelis, S., Kouklakis, G., Kolios, G. C., & Bamias, G. (2018) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izy204 · Cited by 32
Immunological roles of intestinal mesenchymal cells
Thomson, C. A., Nibbs, R. J. B., McCoy, K. D., & Mowat, A. M. (2020) · Immunology · doi:10.1111/imm.13191 · Cited by 32
Oxidative state and IL-6 production in intestinal myofibroblasts of Crohnʼs disease patients
Catarzi, S., Favilli, F., Romagnoli, C., Marcucci, T., Picariello, L., Tonelli, F., VINCENZINI, M. T., & Iantomasi, T. (2010) · Inflammatory Bowel Diseases · doi:10.1002/ibd.21552 · Cited by 32
Sun, S., Wang, X., Wu, X., Zhao, Y. L., Wang, F., Liu, X., Song, Y., Wu, Z., & Liu, M. (2011) · Parasites & Vectors · doi:10.1186/1756-3305-4-186 · Cited by 32
Andoh, A., Ogawa, A., Bamba, S., & Fujiyama, Y. (2007) · Journal of Gastroenterology · doi:10.1007/s00535-006-1926-7 · Cited by 30
Dias, M. M. D. S., Martino, H. S. D., Noratto, G. D., Roque‐Andrade, A., Stringheta, P. C., Talcott, S. T., Ramos, A. M., & Mertens‐Talcott, S. U. (2015) · Food & Function · doi:10.1039/c5fo00278h · Cited by 31
Zhang, L., Fan, J., He, J., Chen, W., Jin, W., Zhu, Y., Sun, H., Li, Y., Shi, Y., Jing, Y., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28133 · Cited by 31
Toll-like receptors in inflammatory bowel disease-stepping into uncharted territory
Levin, A., & Shibolet, O. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.5149 · Cited by 29
Pathogenic aspects and therapeutic avenues of intestinal fibrosis in Crohn's disease
Zorzi, F., Calabrese, E., & Monteleone, G. (2015) · Clinical Science · doi:10.1042/cs20150472 · Cited by 29
Development and Regression of Cirrhosis
Saffioti, F., & Pinzani, M. (2016) · Digestive Diseases · doi:10.1159/000444550 · Cited by 27
Cellular Interactions in the Intestinal Stem Cell Niche
Pastuła, A., & Marcinkiewicz, J. (2018) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-018-0524-8 · Cited by 27
The role of cytokine and immune responses in intestinal fibrosis
Yang, B., Zhang, G., Elias, M. G., Zhu, Y., & Wang, J. (2020) · Journal of Digestive Diseases · doi:10.1111/1751-2980.12879 · Cited by 26
Adipocytes protect fibroblasts from radiation-induced damage by adiponectin secretion
Kosmacek, E. A., & Oberley‐Deegan, R. E. (2020) · Scientific Reports · doi:10.1038/s41598-020-69352-w · Cited by 26
Heidemann, J., Rüther, C., Kebschull, M., Domschke, W., Brüwer, M., Koch, S., Kucharzik, T. F., & Maaser, C. (2007) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00142.2007 · Cited by 25
Chronic Cyclooxygenase-2 Inhibition Promotes Myofibroblast-Associated Intestinal Fibrosis
Davids, J. S., Carothers, A. M., Damas, B. C., & Bertagnolli, M. M. (2010) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-09-0146 · Cited by 25
Contribution of the Gut Microbiota to Intestinal Fibrosis in Crohn's Disease
Watanabe, D., & Kamada, N. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.826240 · Cited by 23
Rieder, F., Bettenworth, D., Imai, J., & Inagaki, Y. (2016) · Inflammatory Intestinal Diseases · doi:10.1159/000445135 · Cited by 25
Recent findings in the cell and molecular biology of the small intestine
Walters, J. R. F. (2005) · Current Opinion in Gastroenterology · doi:10.1097/01.mog.0000153309.13080.8b · Cited by 23
In silico and Ex vivo approaches identify a role for toll-like receptor 4 in colorectal cancer
Sussman, D. A., Santaolalla, R., Bejarano, P. A., Garcia-Buitrago, M. T., Perez, M. T., Abreu, M. T., & Clarke, J. (2014) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/1756-9966-33-45 · Cited by 22
Stromal Cell Regulation of Intestinal Inflammatory Fibrosis
Yang, W., Yu, T., & Cong, Y. (2024) · Cellular and Molecular Gastroenterology and Hepatology · doi:10.1016/j.jcmgh.2024.01.007 · Cited by 21
Regulation of intestinal epithelial homeostasis by mesenchymal cells
Kayama, H., & Takeda, K. (2024) · Inflammation and Regeneration · doi:10.1186/s41232-024-00355-0 · Cited by 23
Intestinal fibrosis associated with inflammatory bowel disease: Known and unknown
Zhang, Y., Zhuang, H., Chen, K., Zhao, Y., Wang, D., Ran, T., & Zou, D. (2025) · Chinese Medical Journal · doi:10.1097/cm9.0000000000003545 · Cited by 21
Barclay, A. R., Morrison, D. J., & Weaver, L. T. (2008) · Journal of Pediatric Gastroenterology and Nutrition · doi:10.1097/mpg.0b013e3181615b3a · Cited by 21
The myofibroblast in connective tissue repair and regeneration
Hinz, B. (2010) · Elsevier eBooks · doi:10.1533/9781845697792.39 · Cited by 20
Intestinal stricture in Crohn's disease: A 2020 update
Lin, X., Qiu, Y., Zhuang, X. J., Liu, F., Wu, X. M., Chen, M. H., & Mao, R. (2021) · Journal of Digestive Diseases · doi:10.1111/1751-2980.13022 · Cited by 19
Macrophage orchestration of epithelial and stromal cell homeostasis in the intestine
Cao, Q., Mertens, R. T., Sivanathan, K. N., Cai, X., & Xiao, P. (2022) · Journal of Leukocyte Biology · doi:10.1002/jlb.3ru0322-176r · Cited by 19
Multidisciplinary Management of Gastrointestinal Fibrotic Stenosis in Crohn’s Disease
Malgras, B., Pautrat, K., Dray, X., Pasquier, P., Valleur, P. D., Pocard, M. D., & Soyer, P. A. (2014) · Digestive Diseases and Sciences · doi:10.1007/s10620-014-3421-y · Cited by 19
Asmuth, D. M., Pinchuk, I. V., Wu, J., Vargas, G., Chen, X., Mann, S. K., Albanese, A. P., Ma, Z.-M., Saroufeem, R. M. G., MELCHER, G. P., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000636 · Cited by 21
Kuete, J. B. T., Kuete, J. R. N., Mbaveng, A. T., Kuete, V., Efferth, T., & Weiskirchen, R. (2025) · Phytomedicine · doi:10.1016/j.phymed.2025.157242 · Cited by 18
Host-Derived Cytotoxic Agents in Chronic Inflammation and Disease Progression
Arnhold, J. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24033016 · Cited by 18
Roles of fibroblasts in the pathogenesis of inflammatory bowel diseases and IBD-associated fibrosis
Ito, T., & Kayama, H. (2025) · International Immunology · doi:10.1093/intimm/dxaf015 · Cited by 17
Cui, Y., Wu, H., Liu, Z., Ma, T., Liang, W., Zeng, Q., Chen, D., Qin, Q., Huang, B., Wang, M. H., et al. (2022) · The Journal of Pathology · doi:10.1002/path.6031 · Cited by 17
Endotoxemic Myocardial Dysfunction
Soriano, F. G., Guido, M. C., Barbeiro, H. V., Caldini, E. T. E. G., Lorigados, C. B., & Nogueira, A. C. (2014) · Shock · doi:10.1097/shk.0000000000000232 · Cited by 17
Intestinal barrier function in neonatal foals: Options for improvement
Vendrig, J. C., & Fink‐Gremmels, J. (2012) · The Veterinary Journal · doi:10.1016/j.tvjl.2012.01.032 · Cited by 17
Edwards, R. A., & Smock, A. Z. (2006) · Inflammatory Bowel Diseases · doi:10.1097/01.mib.0000201100.72191.19 · Cited by 16
Chokr, D., Cornu, M., Neut, C., Bortolus, C., Charlet, R., Desreumaux, P., Speca, S., & Sendid, B. (2021) · Gut Pathogens · doi:10.1186/s13099-021-00401-z · Cited by 16
Cabrera, G. B., Estrada-Luna, D., Belefant‐Miller, H., & Cancino‐Díaz, J. C. (2012) · PubMed · doi:10.3305/nh.2012.27.4.5842 · Cited by 16
Jin, X., Qin, Q., Tu, L., & Qu, J. (2009) · PubMed Central · Cited by 16
Luna, J., Masamunt, M. C., Lawrance, I. C., & Sans, M. (2011) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00504.2010 · Cited by 17
Guarino, M. P. L., Sessa, R., Altomare, A., Cocca, S., Di Pietro, M., Carotti, S., Schiavoni, G., Alloni, R., Emerenziani, S., Morini, S., et al. (2013) · Digestive and Liver Disease · doi:10.1016/j.dld.2013.06.001 · Cited by 15
Trends and Outcomes for Minimally Invasive Surgery for Inflammatory Bowel Disease
Gaglani, T., Davis, C. H., Bailey, H. R., & Cusick, M. V. (2018) · Journal of Surgical Research · doi:10.1016/j.jss.2018.09.075 · Cited by 15
Immunosuppression by Intestinal Stromal Cells
Pinchuk, I. V., & Powell, D. W. (2018) · Advances in experimental medicine and biology · doi:10.1007/978-3-319-78127-3_7 · Cited by 17
Establishment of mouse intestinal myofibroblast cell lines
Kawasaki, H. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i17.2629 · Cited by 15
Cellular crosstalk mechanism of Toll-like receptors in gingival overgrowth (Review)
Subramani, T., Rathnavelu, V., Alitheen, N. B., & Padmanabhan, P. (2015) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2015.2144 · Cited by 15
Not an immune cell, but they may act like one—cells with immune properties outside the immune system
Typiak, M. J., & Żurawa‐Janicka, D. (2024) · Immunology and Cell Biology · doi:10.1111/imcb.12752 · Cited by 12
Small Interfering RNA Targeting Focal Adhesion Kinase Prevents Cardiac Dysfunction in Endotoxemia
Guido, M. C., Clemente, C. F. M. Z., Moretti, A. I. S., Barbeiro, H. V., Debbas, V., Caldini, E. T. E. G., Franchini, K. G., & Soriano, F. G. (2011) · Shock · doi:10.1097/shk.0b013e31823532ec · Cited by 12
Lipopolysaccharide responsiveness in vocal fold fibroblasts
King, S. N., Berchtold, C. M., & Thibeault, S. L. (2014) · Journal of Inflammation · doi:10.1186/s12950-014-0042-3 · Cited by 12
Murine Precision-cut Intestinal Slices as a Potential Screening Tool for Antifibrotic Drugs
Iswandana, R., Pham, B. T., Suriguga, S., Luangmonkong, T., van Wijk, L. A., Jansen, Y. J. M., Oosterhuis, D., Mutsaers, H. A. M., & Olinga, P. (2020) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izz329 · Cited by 12
Grillo, A. R., Scarpa, M., Renata D'Incà, Brun, P., Scarpa, M., Porzionato, A., De, R., Martines, D., Buda, A., Angriman, I., et al. (2015) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00400.2014 · Cited by 12
Editorial: Can Stenosis in Ileal Crohn's Disease Be Prevented by Current Therapy?
Limketkai, B. N., & Bayless, T. M. (2013) · The American Journal of Gastroenterology · doi:10.1038/ajg.2013.301 · Cited by 12
Kim, D.-H., Seo, S., Zeng, M. Y., Kim, W., Kamada, N., Inohara, N., & Núñez, G. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601527 · Cited by 11
Toll-like receptors: emerging targets of immunomodulation
Quesniaux, V. F. J., & Ryffel, B. (2004) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.14.1.85 · Cited by 11
Childress, K. O., Cencer, C. S., Tyska, M. J., & Lacy, D. B. (2023) · mBio · doi:10.1128/mbio.01857-23 · Cited by 10
Human foetal intestinal fibroblasts are hyper-responsive to lipopolysaccharide stimulation
Okogbule-Wonodi, A. C., Li, G., Anand, B., Luzina, I. G., Atamas, S. P., & Blanchard, T. G. (2011) · Digestive and Liver Disease · doi:10.1016/j.dld.2011.08.017 · Cited by 10
Alcoholic and Non-alcoholic Fatty Liver in Adolescents: A Worrisome Convergence
Nobili, V., & Pinzani, M. (2011) · Alcohol and Alcoholism · doi:10.1093/alcalc/agr074 · Cited by 10
The Multiple Faces of Integrin–ECM Interactions in Inflammatory Bowel Disease
Garlatti, V., Lovisa, S., Danese, S., & Vetrano, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910439 · Cited by 9
Eleftheriadis, T., Liakopoulos, V., Lawson, B. R., Antoniadi, G., Stefanidis, I., & Galaktidou, G. (2011) · PubMed Central · Cited by 8
Chulkina, M., Tran, H. T. D., Uribe, G., McAninch, S. B., McAninch, C., Seideneck, A. M., He, B., Lanza, M. R., Khanipov, K., Golovko, G., et al. (2025) · Cell Reports · doi:10.1016/j.celrep.2025.115553 · Cited by 7
Fibrosis in the GI Tract: Pathophysiology, Diagnosis and Treatment Options
Pinzani, M. (2009) · Frontiers of gastrointestinal research · doi:10.1159/000258275 · Cited by 7
Inflammatory and Immune Activation in Intestinal Myofibroblasts Is Developmentally Regulated
Zawahir, S., Li, G., Banerjee, A., Shiu, J., Blanchard, T. G., & Okogbule-Wonodi, A. C. (2015) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2014.0071 · Cited by 7
Lutz, C., Weder, B., Hünerwadel, A., Fagagnini, S., Lang, B. M., Beerenwinkel, N., Rossel, J., Rogler, G., Misselwitz, B., & Hausmann, M. (2017) · Scientific Reports · doi:10.1038/s41598-017-17755-7 · Cited by 7
Genetic advances in inflammatory bowel disease
Cho, J. H. (2006) · Current Treatment Options in Gastroenterology · doi:10.1007/s11938-006-0038-z · Cited by 7
Eckmann, L. (2006) · Elsevier eBooks · doi:10.1016/b978-012088394-3/50045-3 · Cited by 6
Fang, L., Peng, H., Tan, Z., Deng, N., & Peng, X. (2025) · Journal of Inflammation Research · doi:10.2147/jir.s504827 · Cited by 7
Uprety, T., Spurlin, B. B., Antony, L., Sreenivasan, C. C., Young, A. J., Li, F., Hildreth, M. B., & Kaushik, R. S. (2019) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-019-00365-0 · Cited by 5
Medical Therapy of Fibrostenotic Crohn's Disease
Siegmund, B. (2015) · Visceral Medicine · doi:10.1159/000435868 · Cited by 5
Metadata
- Authors
- Otte, J.-M., Rosenberg, I. M., & Podolsky, D. K.
- Affiliations
- Harvard University (US)
- Corresponding author
- Podolsky, Daniel K
- ORCID
- Podolsky, Daniel K
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2003-06
- Volume
- 124
- Issue
- 7
- Pages
- 1866-1878
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W1984107869
- Cited by
- 242
- References
- 63
- Citations by year
- 2026: 3 · 2025: 6 · 2024: 7 · 2023: 5 · 2022: 6 · 2021: 9 · 2020: 11 · 2019: 10 · 2018: 15 · 2017: 7 · 2016: 6 · 2015: 17 · 2014: 12 · 2013: 11 · 2012: 16
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institute of Diabetes and Digestive and Kidney Diseases (P30DK 433-51, R01 DK 60049, R01DK060049, P30DK043351)
- Topics
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Health Sciences › Medicine › Gastroenterology › Inflammatory Bowel Disease
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- intestinal myofibroblasts, innate immunity, Toll-like receptors, NOD1, NOD2, lipopolysaccharide, lipoteichoic acid, MyD88, TIRAP, MAPK signaling, p65 nuclear translocation, interleukin-8, colonic myofibroblasts, lung myofibroblasts, bacterial sensing
- MeSH terms
- Cells, Cultured, Colon, Fibroblasts, Humans, Immunity, Innate, Intestinal Mucosa, Lipopolysaccharides, Membrane Glycoproteins, Receptors, Cell Surface, RNA, Messenger, Teichoic Acids, Inflammatory Bowel Diseases, Interleukin-8, Reverse Transcriptase Polymerase Chain Reaction, Oligonucleotide Array Sequence Analysis, Mitogen-Activated Protein Kinases, Toll-Like Receptors, Toll-Like Receptor 1, Toll-Like Receptor 2
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review